Unless the defendant Sanofi-Aventis reaches a global settlement, the first “bellwether” cases in current mass litigation over the chemotherapy drug Taxotere (docetaxel) will go before a jury starting in May 2019.
His Holiness Pope Francis has drawn some criticism in recent months for his failure to speak out more forcefully on the issue of child sexual abuse by clergy or take meaningful action. This week, however, he did publicly announce that the Chuch is “working on” the sexual abuse and exploitation of nuns by male clergy.
California Wildfires Appear to be a Year-Round Danger. Meanwhile, PG&E Seeks Bankruptcy “Protection”
Global climate change has begun a vicious cycle in California. What was once a seasonal hazard is now 12 months a year, according to a report published earlier this month in Bloomberg. Because of warming, large areas of the Golden State have been “riddled with pockets of dry bush” and nearly 130 million trees have died. As a result, wildfire danger is now constant, not just during summer and early fall.
In August of 2018, the 3M Corporation entered into a $9.1 million settlement with the U.S. government over allegations that it had deliberately sold defective equipment to the Department of Defense. The equipment in question was the Combat Arms Earplugs Version 2, or CAEv2.
For the first time in U.S. history, the risk of dying from an opioid overdose is greater than that of being killed in a traffic accident. Opioids also exceed slip and fall incidents, drowning, and fire as causes of unintentional deaths. Furthermore, only 13 states (including the District of Columbia) are making any progress in dealing with the crisis.
Aurobindo Pharma USA, Inc. has issued a voluntary recall of three of its sartan-based prescription medications after discovering trace amounts of a carcinogenic substance known as N-nitrosodiethylamine (NDEA). The recall, which the FDA announced on Dec. 31st, affects a total of 80 lots of Valsartan, Amlodipine Valsartan, and Valsartan HCTZ pills with expiration dates between May 2019 and March 2021.
This week, Illinois Attorney General Lisa Madigan reported that more than 500 cases of child sexual abuse were swept under the rug by the six Roman Catholic dioceses across the state. Earlier, the Church reported 185 members of the clergy who had “credible allegations” leveled against them. However, according to AG Madigan's report, the real number is 690.
With all eyes on Pennsylvania and the shocking grand jury report that was released earlier this fall, it is easy to forget that cases of pedophile priests in the Roman Catholic Church is a worldwide scandal.
One of the challenges when it comes to determining damages in injury lawsuits is putting a monetary value on intangible losses, such as pain and suffering, emotional distress, and anxiety. These are considered to be “non-economic damages,” and fall under the category of “mental anguish.” Putting a dollar figure on emotional pain is difficult, but it is nonetheless a factor that can diminish the quality of life as surely as a crippling injury.
After two years of clinical trials, a new type of IVC filter was recently implanted in a number of patients under “real world” conditions in an Arizona hospital. The product is called the “Sentry” and is produced by BTG Interventional Medicine, a company based in the UK.
Introduced this month at Vascular Interventional Advances Conference in Las Vegas, the new IVC filter has what the manufacturer describes as a “unique bioconversion feature”, making retrieval of the device unnecessary.
Environmental activist groups in Canada have accused the country's health ministry, Health Canada, of being secretly influenced by Monsanto when it renewed its approval of the chemical glyphosate, the primary ingredient in the company's flagship product, RoundupTM.
For the second time in as many weeks, the Food and Drug Administration has notified physicians and patients that yet another sartan drug used to treat hypertension has been contaminated with a carcinogenic industrial chemical. The manufacturer of the drug has issued a voluntary recall for a single lot of the medication losartan (potassium hydrochlorothiazide), identified as JB8912.
Australian researchers recently published a study that has found a link between the use of proton pump inhibitors (PPIs) and iron deficiency. When iron levels in the body are insufficient, it can lead to anemia, a condition in which the amount of hemoglobin (red blood cells) decline to dangerously low levels. Untreated, anemia puts excess strain on the heart muscle, causing a lack of oxygen and leading to serious organ damage. In extreme cases, it can be fatal.
Levin Papantonio Thomas Mitchell Rafferty & Proctor P.A. of Pensacola, Florida, one of the nation’s preeminent Plaintiffs law firms, announced today that it has won a verdict along with John F. Nevares & Associates of Santurce, Puerto Rico, in a FINRA Arbitration against UBS Financial Services Inc. (UBS) and UBS Financial Services Inc. of Puerto Rico (UBS-PR). The verdict, for total damages in excess of $19 million, was obtained on behalf of their client in FINRA Arbitration # 15-01833.
In a recent decision by a Florida federal judge, Abilify maker Otsuka Pharmaceuticals was absolved of responsibility to preserve company e-mails that might have served as evidence for plaintiffs in current Abilify litigation. The reason: the emails were written years ago, long before the company could reasonably have anticipated having to defend itself against lawsuits.